Site language
Ru En
Социальные сети

bitcoinmagazine.com Kenya’s New VASP Law: A No-BS Legal Guide for Bitcoin and Crypto Builders

Bitcoin Magazine Kenya’s New VASP Law: A No-BS Legal Guide for Bitcoin and Crypto Builders This is a clear, candid, and practical explainer for Kenyan Bitcoin and crypto company founders, lawyers, compliance officers, and informed readers seeking a concise legal summary of the Virtual Asset Service Providers Act — what it regulates, what it doesn't, and what you need to know to stay compliant whilst preserving your freedom to innovate. This post Kenya’s New VASP Law: A No-BS Legal Guide for Bitcoin and Crypto Builders first appeared on Bitcoin Magazine and is written by Robert Kirubi.

bitcoinist.com Solana Price Prediction by ChatGPT: 200% Rally Incoming – Snorter Token Could Be Next 1000x Crypto

Quick Facts: 1️⃣ Solana has taken strong support from a major upward trendline after Friday’s massive liquidation, signaling a potential rebound. 2️⃣ According to ChatGPT’s Solana price prediction, a breakout above $250 could propel the token toward $575 – a stunning 200% upside. 3️⃣ Investors are backing Snorter Token ($SNORT) as the next 1000x crypto, […]

blockonomi.com Best Growth Stocks to Buy in October

TLDR Alphabet holds over 90% market share in search and is successfully integrating AI features like Circle to Search and AI Overviews to maintain dominance Google Cloud revenue grew 32% to $13.6 billion last quarter, with operating income more than doubling to $2.8 billion year over year Alphabet raised its 2025 capital expenditure budget by [...] The post Best Growth Stocks to Buy in October appeared first on Blockonomi.

blockonomi.com Solana Price Prediction: Blockchain Analysis Shows Solana Holders Piling Into This Viral Crypto ICO

Solana price prediction is attracting institutional investors and retail investors alike. Technicals show that SOL may bounce as high as $300 as momentum advances. At the same time, Solana holders are reportedly showing interest in Remittix, a viral crypto ICO gaining traction on social platforms. This shift hints at how investors weigh established networks versus [...] The post Solana Price Prediction: Blockchain Analysis Shows Solana Holders Piling Into This Viral Crypto ICO appeared first on Blockonomi.

news.bitcoin.com Bitcoin Price Watch: Short-Term Charts Hint at Accumulation—But Don’t Blink

Another day, another dance on the crypto high wire. Bitcoin may be clinging just above the $111K ledge, but the charts are less interested in a party and more in plotting their next move—quietly, methodically, and with just a hint of drama. Bitcoin Chart Outlook Let’s start with the daily chart, where the grand stage […]

altcoinbuzz.io Polygon Expands in Europe with ODDO BHF Stablecoin

The founder and CEO of Polygon recently highlighted the network’s growth, stating that Polygon’s presence in Europe rivals its dominance in Southeast Asia and Latin America. This expansion was underscored by the announcement that ODDO BHF, a 175-year-old French banking giant, launched its Euro-backed stablecoin, EUROD, exclusively on Polygon. The launch represents a significant milestone […] The post Polygon Expands in Europe with ODDO BHF Stablecoin appeared first on Altcoin Buzz.

blockonomi.com Mira Pharmaceuticals (MIRA) Stock Rockets After Pain Drug Tops Morphine in Trials

TLDR Mira Pharmaceuticals stock jumped 70% after-hours following preclinical data showing oral drug Mira-55 outperformed injected morphine in pain relief and inflammation reduction. The study found Mira-55 fully normalized pain thresholds and reduced swelling through CB2 receptor action, while morphine only partially reduced inflammation. The non-psychotropic marijuana analog targets the $70 billion non-opioid pain market [...] The post Mira Pharmaceuticals (MIRA) Stock Rockets After Pain Drug Tops Morphine in Trials appeared first on Blockonomi.

blockonomi.com Omeros (OMER) Stock Rallies 149% on $2 Billion Novo Nordisk Deal

TLDR Omeros Corporation stock jumped 149% to $10.19 after signing a $2.1 billion licensing deal with Novo Nordisk for its MASP-3 inhibitor drug zaltenibart. Novo Nordisk will pay $340 million upfront and near-term payments, with potential milestone payments reaching $2.1 billion total. Trading volume exploded to 77.9 million shares compared to the typical 1.2 million [...] The post Omeros (OMER) Stock Rallies 149% on $2 Billion Novo Nordisk Deal appeared first on Blockonomi.